|
FY2014
12 months to Jan 3, 2015
|
FY2013
12 months to Dec 28, 2013
|
FY2012
12 months to Dec 29, 2012
|
FY2011
12 months to Dec 31, 2011
|
FY2010
12 months to Jan 1, 2011
|
|
|---|---|---|---|---|---|
| Product sales | |||||
| Cost of product sales, excluding impairment of PVAD and IVAD intangible assets | |||||
| Impairment of intangible assets | |||||
| Impairment of PVAD and IVAD intangible assets | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Amortization of purchased intangible assets | |||||
| Total operating expenses | |||||
| Income from operations | |||||
| Other income (expense): | |||||
| Interest expense | |||||
| Impairment on investment | |||||
| Interest income and other | |||||
| Income before taxes | |||||
| Income tax expense | |||||
| Net income from continuing operations | |||||
| Net income | |||||
| Net income per share: | |||||
| Continuing operations (in dollars per share) | |||||
| Basic (in dollars per share) | |||||
| Continuing operations (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Shares used to compute net income per share: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...